These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 24799155)
61. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Iwakura K; Ito H; Kawano S; Okamura A; Kurotobi T; Date M; Inoue K; Fujii K Eur Heart J; 2006 Mar; 27(5):534-9. PubMed ID: 16401674 [TBL] [Abstract][Full Text] [Related]
62. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY; Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142 [TBL] [Abstract][Full Text] [Related]
63. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. Iwakura K; Ito H; Ikushima M; Kawano S; Okamura A; Asano K; Kuroda T; Tanaka K; Masuyama T; Hori M; Fujii K J Am Coll Cardiol; 2003 Jan; 41(1):1-7. PubMed ID: 12570936 [TBL] [Abstract][Full Text] [Related]
64. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Brosh D; Assali AR; Mager A; Porter A; Hasdai D; Teplitsky I; Rechavia E; Fuchs S; Battler A; Kornowski R Am J Cardiol; 2007 Feb; 99(4):442-5. PubMed ID: 17293180 [TBL] [Abstract][Full Text] [Related]
66. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. Jaffe R; Dick A; Strauss BH JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430 [TBL] [Abstract][Full Text] [Related]
67. Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction. Funayama H; Ishikawa SE; Sugawara Y; Kubo N; Momomura S; Kawakami M Int J Cardiol; 2010 Mar; 139(2):187-92. PubMed ID: 19138806 [TBL] [Abstract][Full Text] [Related]
68. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272 [TBL] [Abstract][Full Text] [Related]
69. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status. De Luca G; Suryapranata H; Marino P Prog Cardiovasc Dis; 2008; 50(5):352-82. PubMed ID: 18313480 [TBL] [Abstract][Full Text] [Related]
70. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273 [TBL] [Abstract][Full Text] [Related]
71. Mechanism and potential treatment of the "no reflow" phenomenon after acute myocardial infarction: role of pericytes and GPR39. Methner C; Cao Z; Mishra A; Kaul S Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1030-H1041. PubMed ID: 34623177 [TBL] [Abstract][Full Text] [Related]
72. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction. Werner GS; Lang K; Kuehnert H; Figulla HR Catheter Cardiovasc Interv; 2002 Dec; 57(4):444-51. PubMed ID: 12455077 [TBL] [Abstract][Full Text] [Related]
73. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention. Movahed MR; Butman SM Cardiovasc Revasc Med; 2008; 9(1):56-61. PubMed ID: 18206640 [TBL] [Abstract][Full Text] [Related]
74. Post-infarction microvascular integrity predicts myocardial viability and left ventricular remodeling after primary coronary angioplasty. A study performed with intravenous myocardial contrast echocardiography. Colonna P; Cadeddu C; Montisci R; Ruscazio M; Chen L; Onnis E; Meloni L; Iliceto S Ital Heart J; 2002 Sep; 3(9):506-13. PubMed ID: 12407846 [TBL] [Abstract][Full Text] [Related]
76. Impact of metabolic syndrome on no-reflow after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Celik T; Iyisoy A Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):e21-2. PubMed ID: 18378434 [No Abstract] [Full Text] [Related]
77. Clinical and postmortem outcome of "no-reflow' phenomenon in a patient treated with rotational atherectomy. Bowles M; Palko W; Beaver C; Cowley C; Kipperman R South Med J; 1996 Aug; 89(8):820-3. PubMed ID: 8701386 [TBL] [Abstract][Full Text] [Related]
78. Modulation of individual susceptibility to the no-reflow phenomenon after acute myocardial infarction. Iwakura K Curr Pharm Des; 2013; 19(25):4519-28. PubMed ID: 23270556 [TBL] [Abstract][Full Text] [Related]
79. Distal protection beneficial? van der Wall EE; Bax JJ; Jukema JW; Schalij MJ Int J Cardiovasc Imaging; 2010 Feb; 26(2):135-8. PubMed ID: 20175293 [No Abstract] [Full Text] [Related]
80. Three-dimensional microstructural abnormality of the coronary capillary network after myocardial reperfusion--comparison between 'reflow' and 'no-reflow'. Watanabe N; Akasaka T; Toyota E; Fujimoto K; Kajita T; Shigeto F; Ogasawara Y; Yoshida K Circ J; 2004 Sep; 68(9):868-72. PubMed ID: 15329510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]